Experimental drug may protect the heart in Duchenne muscular dystrophy

Researchers astatine the USF Health Morsani College of Medicine person identified a imaginable pathway that could support cardiac relation successful radical with Duchenne muscular dystrophy (DMD), a progressive and fatal familial illness that weakens the body's muscles. Published successful Molecular Therapy, the caller survey examined the effects of the experimental cause Setanaxib successful 2 preclinical models of DMD.